The Ebola outbreak in the Democratic Republic of the Congo has crossed 10,000 cases, according to figures from the Congolese Ministry of Health cited by allAfrica.com. As of Monday, the country had recorded 10,141 infections and close to 5,000 deaths. The World Health Organization says the response still needs to be widened, and warns that progress depends on reaching affected communities and earning their trust.
Why it matters
This is the seventeenth Ebola outbreak in the DRC's history and the largest the country has faced, allAfrica.com reports. Globally, only the West Africa epidemic of 2014 to 2016 was bigger. The current outbreak is driven by the Bundibugyo virus strain, a rare form of Ebola for which no vaccine or treatment has yet been approved. That leaves health authorities without the ready-made tools that were used against the more common Zaire strain in past emergencies.
The outbreak began in the DRC's vast and unstable eastern region, where conflict, hunger and large-scale displacement have complicated the response. It has since spread to eight provinces, including areas that are difficult for aid teams to reach.
According to allAfrica.com, the WHO said containing the virus "requires continued scale-up of key control measures, greater access to affected areas, and community outreach that builds trust and encourages people to engage with the response." The UN agency is working alongside partners to support the Congolese authorities.
Signs of progress amid a rising toll
Despite the case count, the WHO pointed to developments it described as progress. More than 2,600 people have recovered from the disease, and testing and treatment capacity have both been expanded.
Clinical trials of experimental vaccines are also under way. The studies, named TUMAINI — Swahili for "hope" — will first test whether the Evebro vaccine, which is used against the Zaire strain, can protect people in this outbreak. Doses are being given through ring vaccination, a method that targets the close contacts of confirmed patients rather than the wider population.
Dr. Meg Moherty, the WHO's technical lead for vaccine trials, spoke at the launch of TUMAINI in the city of Bunia on Friday. She noted that the same ring-vaccination strategy was used by the WHO and its partners in Guinea during the West Africa outbreak to help establish the effectiveness of Ervebo. She said scientists are now drawing on that experience to find answers about the Bundibugyo virus.
The WHO has also convened expert groups to review evidence on two other vaccines developed specifically against Bundibugyo, with findings expected to be published this week, according to allAfrica.com.
Kenya tightens its defences
Concern has extended beyond the DRC's borders. A UN humanitarian fund has released more than $2 million to strengthen Ebola preparedness and response in Kenya. The money will support government-led work, including closer surveillance at border crossings and training for rapid response teams and front-line health workers. Resources will also go toward readiness along high-risk refugee and travel routes in the country's northwest.
Kenya has confirmed nine Ebola cases, two of them fatal. All are connected to the country's first case: a Kenyan man who had been working in the DRC and flew to Nairobi through Uganda on 3 October. He died two days later. More than 130 contacts were identified and placed under quarantine, and 20 of them have since been released.
The outbreak has also drawn attention further afield. The Guardian reported that a senior health official described Africa's outbreak as "unprecedented" and warned it could reach the United Kingdom. Punch Newspapers reported that the DRC is recording between 50 and 80 new Ebola cases each day, while LEADERSHIP Newspapers reported that the Norwegian Refugee Council is calling for urgent action. Premium Times Nigeria reported that the WHO has expressed hope even as cases passed 10,000 and deaths approached 5,000.
What happens next will hinge on the vaccine evidence due this week and on whether response teams can widen their reach into the outbreak's hardest-to-access areas.
